Hui-Ju J Chen

This inventor holds 17 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Anti-Viral Compounds. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Enanta Pharmaceuticals, Inc.. Active years: 2002-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hui-Ju J Chen. Retrieved from https://idiyas.com/inventor/hui-ju-j-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 8)

% Patents Active = 76.5

CIPO Patents = 3 (Patent Applications = 9)

EPO Patents = 11 (Patent Applications = 15)

Average Co-Inventor Count = 11.7

ph-index = 4

Forward Citations = 78(Granted Patents)

Company Filing History:

Abbott Laboratories Corporation

patents

3 out of 299

Enanta Pharmaceuticals, Inc.

patents

4. 1 out of 1

Enata Pharmacueticals, Inc.

patent

5. 1 out of 64

Reata Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2002-2018

Loading Chart...

Areas of Expertise:

Anti-Viral Compounds

Hepatitis C

Protease Inhibitors

HIV

Serine Protease

Macrocyclic Compounds

Neuraminidase Inhibitors

Inflammation Modulators

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10053474 - Anti-viral compounds (2018-08-21),

2. 9676797 - Anti-viral compounds (2017-06-13),

3. 9493506 - Macrocyclic hepatitis C serine protease inhibitors (2016-11-15),

4. 9464082 - Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators (2016-10-11),

5. 9309279 - Macrocyclic hepatitis C serine protease inhibitors (2016-04-12),

6. 8951964 - Phenanthridine macrocyclic hepatitis C serine protease inhibitors (2015-02-10),

7. 8937041 - Macrocyclic hepatitis C serine protease inhibitors (2015-01-20),

8. 8748374 - Macrocyclic hepatitis C serine protease inhibitors (2014-06-10),

9. 8653141 - HIV protease inhibiting compounds (2014-02-18),

10. 8642538 - Macrocyclic hepatitis C serine protease inhibitors (2014-02-04),

11. 8497275 - HCV protease inhibitors and uses thereof (2013-07-30),

12. 8420596 - Macrocyclic hepatitis C serine protease inhibitors (2013-04-16),

13. 8193227 - HIV protease inhibiting compounds (2012-06-05),

14. 7902203 - Anti-infective agents (2011-03-08),

15. 7696226 - HIV protease inhibiting compounds (2010-04-13),

Title: The Innovative Journey of Hui-Ju J Chen

Introduction:

Hui-Ju J Chen, a talented inventor based in Grayslake, IL (US), has made significant contributions to the field of innovations with his creative mindset and dedication to pushing boundaries.

Latest Patents:

Hui-Ju J Chen's latest patents showcase his commitment to pioneering new technologies and solutions in various industries, ranging from healthcare to sustainable energy.

Career Highlights:

Throughout his illustrious career, Hui-Ju J Chen has demonstrated a remarkable ability to transform ideas into tangible inventions that have the potential to impact society positively. His innovative spirit and problem-solving skills have led to the development of groundbreaking products.

Collaborations:

Hui-Ju J Chen has actively collaborated with leading research institutions, universities, and companies to further his inventions' reach and impact. His partnerships have been instrumental in bringing his ideas to life and commercializing them successfully.

Conclusion:

In conclusion, Hui-Ju J Chen's journey as an inventor exemplifies the power of innovation and perseverance in driving progress and shaping the future. His passion for creating meaningful change through inventions continues to inspire aspiring inventors worldwide.

Profile summary based on public USPTO records.